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,.o k# {VLO. l/l().. Biotechnology promises to be one of the major Industries of the lf . 
future. It opens up vast new opportunities In major sectors of the 
economy such as agriculture, food processing, waste treatment, 
chemicals and medeclne and could grow as much In the coming years as 
micro-electronics have done In the 1970s and 'Bos. If Europe's 
Industries are unable to exploit Its posslbllltles, they wlll 
serlously damage their ability to compete on world markets. Europe 
wlll also lose many of the benefits which genetic engineering has to 
offer. 
It Is nonetheless a development of technology which arouses strong 
publlc concern and neither Industry nor public opinion wlll have the 
confidence to allow the creation of a major European blotechnology 
Industry until there Is a framework of teglslatlon at the Community 
level. 
The European Commission has now made proposals for the Community legal 
framework which Industry needs and which can ensure technologlcai 
progress white at the same time ensuring protection of publlc health 
and the environment by establlshlng the general principle of prior 
notification and endorsement. Public confidence Is essential ,~ 
European Industry Is to take advantage of the posslbllltles In this 
dynamic new field. 
The Commission has proposed two directives: 
on the contained use of genetlcatty modified micro-organisms, 
which would govern the use of biotechnology In the laboratory or 
as part of a manufacturing process; 
on the deliberate release of genetically modified organisms Into 
the environment, which concerns both experimental releases or the 
marketing throughout the Community of new products containing or 
conslstlng of genetically modified organisms. 
A confusion of natlonal standards 
The need for Community leglslatlon Is underllned by the varied way In 
which Member States have responded to the development of 
biotechnology. Faced with the need to ensure publlc conf!dence whlle 
prov!~t~, a legal framework for Industry, some governments have set up 
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Under the Commission proposals, competent authorities In the Member 
States would be responsible for overseeing projects for deliberate 
release of organisms for research and development purposes (as against 
the marketing of new products). However, these authorities would work 
within the context of Community law. All proposed releases In the 
research and development phase would be notified to them so they could 
review the proposals, endorsing the notification as long as It 
eomplled with the requirements of the directive and provided the risk 
associated with the release was considered acceptable. 
An Information exchange system would be establlshed, under which a 
summary of each notification would be provided to the Commission and 
to all other Member States, which would be free to request'further 
detalls and to make comments. 
Commission proposals governing the marketing of products lnvolvlng new 
organisms do not cover those which are already subject to Community 
leglslatlon, such as medicinal products, veterinary products, 
foodstuffs, feedlngstuffs and additives, plants and animals or any 
other products governed by Community leglslatlon which Includes a 
specific risk assessment. The proposals would apply to the marketing 
of other organisms such as pesticides, herbicides, nitrogen fixing 
bacteria, organisms for degrading toxic chemicals, recovering oll or 
treating waste. 
The system proposed In analagous to the Community arrangements for the 
marketing of chemicals. Manufacturers would provide details of new 
products In confidence to the nattonal competent authorities, together 
with a risk assessment, detalls of use and handling conditions and 
proposals for packaging and label I Ing. Once the competent authority 
was satisfied that the product could safely be placed on the market, 
It would send the dossier to the Commission, which would then forward 
a summary to all other Member States. They would have an opportunity 
to ask further Information or to request changes In the marketing 
conditions. A special committee would be set up to deal with any 
disputes. 
This Community process would be subject to strict time llmlts and to 
rules of confidential lty. Once a product had been endorsed, It could 
be marketed throughout the Community, although If evidence 
subsequently emerged that the product constituted a risk to people or 
to the environment, It might be provlslonally restricted or prohibited 
by a Member State subject to a Commission decision. 
A raoldlv changing sector 
The Commission has Incorporated In Its proposals various provisions 
allowing the leglslatlon to be adapted to changing technologies and 
scientific knowledge and also to changes on the International level. 
It Is anticipated that the OECD, for example, wf 11 develop new 
guidelines In this sector, which could be reflected In Community law. 
Commenting on the new proposals, Commissioner Stanley Clinton Davis 
stressed the Commission's two essentlal alms: to protect people's 
health and avoid damage to the environment, white at the same time 
allowlng Europe to explolt the enormous benefits of genetic 
./. 
englneef1ng. "If we are to bulld a major blotechnology Industry In 
the Community, we must retain the confidence of the publlc. We have 
proposed a legal framework wnlch wltl establlsh effective safeguards 
for human health and the world around us, without unnecessarily 
cramping creative Innovation In European Industry." 
some uses of genetic engineering 
Blotechnology In the form of genetic engineering, has an Infinite 
range of appllcatlons. It essentla11y means changing the 
characteristics of micro-organisms such as viruses, bacteria, fungi, 
and llvlng cell cultures, by modifying their genetic structure so that 
they can fulfil new functions. 
In Its pr9posals on contained use, the Commission provides for two 
groups of genetically modified micro-organisms. Most micro-organisms 
would be In the first group, which Is of virtually zero risk. They 
would be used In the following types of process: 
production of rennet from yeast rather than from the stomach of a 
COW; 
production of citric acid from sugar; 
making of Insulin or Interferon; 
modifying the fermentation agent In yoghurt so It would no longer 
risk souring the product. 
The second group covers applications where there Is a higher degree of 
risk. A typical example here would be: 
production of vaccines where the pathogenic characteristic has 
been ellmlnated by the use of genetic engineering, so rendering 
the vaccine entlrely safe. 
Among the genetically modified organisms which might be dellbarately 
released to the environment would be: 
potatoes which have been given Improved disease resistance; 
cereal crops which have acquired the ab;11ty to create their own 
nitrogen; 
organisms with the power to disperse oll pollutants at sea; 
organisms able to extract metals from minerals, to break down 
household waste~ to start compost heaps or to make sllage; 
livestock with Improved production or disease resistance 
characteristics produced by genetic modification. 
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